UTHSC and Regional One Health Collaborate to Bring Promising COVID-19 Treatment Clinical Trial to Memphis
September 25, 2020
September 25, 2020
MEMPHIS, Tennessee, Sept. 25 -- The University of Tennessee Health Science Center issued the following news on Sept. 24:
The University of Tennessee Health Science Center and Regional One Health today are announcing that they are partnering on a clinical trial program including two late-stage clinical trials evaluating Regeneron's REGN-COV2, the company's investigational two-antibody cocktail for the treatment and prevention of COVID-19.
Leading the efforts ar . . .
The University of Tennessee Health Science Center and Regional One Health today are announcing that they are partnering on a clinical trial program including two late-stage clinical trials evaluating Regeneron's REGN-COV2, the company's investigational two-antibody cocktail for the treatment and prevention of COVID-19.
Leading the efforts ar . . .